---
title: "HENGFENG PAPER released its performance for the first half of the year, with a net profit attributable to shareholders of 94.9367 million yuan, a year-on-year increase of 69.06%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254753554.md"
description: "HENGFENG PAPER released its semi-annual report for 2025, reporting an operating income of 1.353 billion yuan, a year-on-year increase of 12.78%; net profit attributable to shareholders of 94.9367 million yuan, a year-on-year increase of 69.06%; net profit excluding non-recurring gains and losses of 85.3786 million yuan, a year-on-year increase of 96.57%; basic earnings per share of 0.32 yuan"
datetime: "2025-08-27T07:47:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254753554.md)
  - [en](https://longbridge.com/en/news/254753554.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254753554.md)
---

# HENGFENG PAPER released its performance for the first half of the year, with a net profit attributable to shareholders of 94.9367 million yuan, a year-on-year increase of 69.06%

According to the Zhitong Finance APP, HENGFENG PAPER (600356.SH) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 1.353 billion yuan, a year-on-year increase of 12.78%. The net profit attributable to shareholders of the listed company was 94.9367 million yuan, a year-on-year increase of 69.06%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 85.3786 million yuan, a year-on-year increase of 96.57%. The basic earnings per share were 0.32 yuan

### Related Stocks

- [600356.CN](https://longbridge.com/en/quote/600356.CN.md)

## Related News & Research

- [Bain-backed Dhoot Transmission jumps in India debut, valued at $2.5 billion](https://longbridge.com/en/news/296057696.md)
- [Lundbeck Foundation unit Lundbeckfond Invest launches voluntary exchange offer for Lundbeck A-shares](https://longbridge.com/en/news/296304407.md)
- [GRAINS-Soybeans near three-week high on China demand, crop worries](https://longbridge.com/en/news/296295616.md)
- [Tvardi Therapeutics: TTI-109, an oral STAT3 inhibitor, targets unmet needs in UC with promising safety and efficacy data](https://longbridge.com/en/news/296388332.md)
- [CMH unit to buy directors-linked rental property portfolio for ZAR 745 million](https://longbridge.com/en/news/296314293.md)